("hepatitis c" AND hiv) AND ((clinical[Title/Abstract] AND trial[Title/Abstract]) OR clinical trials[MeSH Terms] OR clinical trial[Publication Type] OR random*[Title/Abstract] OR random allocation[MeSH Terms] OR therapeutic use[MeSH Subheading])

Trullàs JC, Barril G, Cofan F, Moreno A, Cases A, Fernandez-Lucas M, Martinez-Ara J, Ceballos M, Garcia-de-Diego J, Muñiz ML, Molina J, Martínez-Castelao A, González-Garcia J, Miró JM; and the Spanish HIV Infection in Dialysis Study Group.

AIDS Res Hum Retroviruses. 2008 Oct;24(10):1229-35.

PMID: 18834322 [PubMed - indexed for MEDLINE]

Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.

Fätkenheuer G, Nelson M, Lazzarin A, Konourina I, Hoepelman AI, Lampiris H, Hirschel B, Tebas P, Raffi F, Trottier B, Bellos N, Saag M, Cooper DA, Westby M, Tawadrous M, Sullivan JF, Ridgway C, Dunne MW, Felstead S, Mayer H, van der Ryst E; MOTIVATE 1 and MOTIVATE 2 Study Teams.

N Engl J Med. 2008 Oct 2;359(14):1442-55.

PMID: 18832245 [PubMed - indexed for MEDLINE]

Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention, and treatment options.

Tebas P.

J Acquir Immune Defic Syndr. 2008 Sep 1;49 Suppl 2:S86-92. Review.

PMID: 18725817 [PubMed - indexed for MEDLINE]

[Guideline 'Needlestick injuries': risk assessment and post-exposure management in practice]

Ruijs WL, Timen A.

Ned Tijdschr Geneeskd. 2008 Sep 6;152(36):1967-71. Review. Dutch.

PMID: 18807333 [PubMed - indexed for MEDLINE]

10:

CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.

Khanna N, Opravil M, Furrer H, Cavassini M, Vernazza P, Bernasconi E, Weber R, Hirschel B, Battegay M, Kaufmann GR; Swiss HIV Cohort Study.

Clin Infect Dis. 2008 Oct 15;47(8):1093-101.

PMID: 18783328 [PubMed - indexed for MEDLINE]

11:

Incidence of abacavir hypersensitivity reactions in euroSIDA.

Bannister WP, Friis-Møller N, Mocroft A, Viard JP, van Lunzen J, Kirk O, Gargalianos P, Bánhegyi D, Chiesi A, Lundgren JD; EuroSIDA Study Group.

Antivir Ther. 2008;13(5):687-96.

PMID: 18771052 [PubMed - indexed for MEDLINE]

12:

Emerging antiviral drugs.

De Clercq E.

Expert Opin Emerg Drugs. 2008 Sep;13(3):393-416. Review.

PMID: 18764719 [PubMed - indexed for MEDLINE]

13:

Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004.

Larsen C, Pialoux G, Salmon D, Antona D, Le Strat Y, Piroth L, Pol S, Rosenthal E, Neau D, Semaille C, Delarocque Astagneau E.

Euro Surveill. 2008 May 29;13(22). pii: 18888.

PMID: 18761958 [PubMed - indexed for MEDLINE]

14:

The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis.

Wyatt CM, Malvestutto C, Coca SG, Klotman PE, Parikh CR.

AIDS. 2008 Sep 12;22(14):1799-807. Review.

PMID: 18753863 [PubMed - indexed for MEDLINE]

15:

Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy.

Zanone Poma B, Riva A, Nasi M, Cicconi P, Broggini V, Lepri AC, Mologni D, Mazzotta F, Monforte AD, Mussini C, Cossarizza A, Galli M; Icona Foundation Study Group.

AIDS. 2008 Sep 12;22(14):1769-78.

PMID: 18753860 [PubMed - indexed for MEDLINE]

16:

Classification of hepatitis C virus and human immunodeficiency virus-1 sequences with the branching index.

Hraber P, Kuiken C, Waugh M, Geer S, Bruno WJ, Leitner T.

J Gen Virol. 2008 Sep;89(Pt 9):2098-107.

PMID: 18753218 [PubMed - indexed for MEDLINE]

17:

Co-infection at the 2008 Retrovirus Conference. Liver fibrosis, hep c treatment, and the role of ART.

Highleyman L.

Posit Aware. 2008 May-Jun;19(3):32-3. No abstract available.

PMID: 18724446 [PubMed - indexed for MEDLINE]